Image

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This study will be a pilot study to evaluate the feasibility, safety and acceptability of Exercise and Liver FITness (EL-FIT), a mHealth exercise training program previously validated in patients with cirrhosis in patients with nonalcoholic steatohepatitis.

Eligibility

Inclusion Criteria:

  • Adults age >18 years
  • Evidence of NASH indicated by at least one of the following
    • Liver biopsy with evidence of steatohepatitis (NAS >=4) within 6 months of the screening interval or;
    • Historical Imaging study (e.g., ultrasound, CT, MRI) with hepatic steatosis and one of the following non-invasive tests within 6 months of the screening interval: i. FIB-4 >= 1.3 or; ii. NFS >= -1.44 or; iii. ELF >= 7.7 or; iv. VCTE kPa >=8 or; v. ARFI >=1.3 or; vi. FAST >= 0.35 or; vii. MRE kPa >=2.55 or; viii. MAST > 0.165 or;
  • Possession of a smartphone

Exclusion Criteria:

  • Active cardiac symptoms precluding participation in vigorous exercise
  • Active or recent participation in exercise training program within the last 90 days
  • Active or recent weight-loss supplement use within the last 90 days (does not include GLP-1 receptor agonist use)
  • Active illicit substance use
  • Cancer that is active
  • Cirrhosis
  • Exercise identified to be unsafe by study PI or EL-FIT mHealth program
  • Inability to provide informed consent
  • Inability to walk > 2 blocks
  • Institutionalized/prisoner
  • Other chronic liver disease (e.g., viral hepatitis)

Study details
    NASH - Nonalcoholic Steatohepatitis
    NASH
    Exercise
    Liver

NCT06195943

Milton S. Hershey Medical Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.